Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigator Sponsored Trial of Polypoidal Choroidal Vasculopathy (PCV) Evaluation Assessing High-Dose Ranibizumab (2.0mg) Prospectively

NCT01248117 is registered in ClinicalTrials.gov with Retina Consultants of Hawaii as lead sponsor.

NCT NCT01248117
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01248117 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigator Sponsored Trial of Polypoidal Choroidal Vasculopathy (PCV) Evaluation Assessing High-Dose Ranibizumab (2.0mg) Prospectively
Lead sponsor
Retina Consultants of Hawaii
Phase
Phase 1/2
Overall status
Unknown status
Start date
November 30, 2010
Completion date
February 28, 2013
Enrollment
20 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

polypoidal choroidal vasculopathy